株探米国株
日本語 英語
エドガーで原本を確認する
0001670541FALSE00016705412025-05-072025-05-07

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934

Date of Report (date of earliest event reported): May 7, 2025

ADIENT PLC
(Exact name of registrant as specified in its charter)

Ireland 001-37757 98-1328821
(State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification Number)
 3 Dublin Landings, North Wall Quay
Dublin 1, Ireland D01 H104
(Address of principal executive offices)

Registrant’s telephone number, including area code: 734-254-5000

Not applicable
(Former name or former address, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:
Title of class Trading symbol(s) Name of exchange on which registered
Ordinary Shares, par value $0.001 ADNT New York Stock Exchange


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrants under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17     CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))




Indicate by check mark whether the Registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐





Item 2.02 Results of Operations and Financial Condition.

On May 7, 2025, Adient plc (the “Company”) issued a news release announcing its financial results for the second quarter ended March 31, 2025. The news release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

The information contained in Exhibit 99.1 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.


Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.
EXHIBIT INDEX
Exhibit No. Exhibit Description
99.1
104
Cover Page Interactive Data File (the Cover Page Interactive Data File is embedded within the Inline XBRL document).



SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

ADIENT PLC
Date: May 7, 2025 By: /s/ Heather M. Tiltmann
Name: Heather M. Tiltmann
Title:
Executive Vice President, Chief Legal and Human Resources Officer, and Corporate Secretary

EX-99.1 2 a05072025adientform8-kex991.htm EX-99.1 Document
Exhibit 99.1
q2fy25-earningsinfographic.jpg




q2fy25-earningsinfographica.jpg




q2fy25-earningsinfographicb.jpg



q2fy25-earningsinfographicc.jpg


Appendix
Page 1

Adient plc
Condensed Consolidated Statements of Income (Loss)
(Unaudited)
Three Months Ended
March 31,
(in millions, except per share data) 2025 2024
Net sales $ 3,611  $ 3,750 
Cost of sales 3,350  3,520 
Gross profit 261  230 
Selling, general and administrative expenses 144  115 
Restructuring and impairment costs 351  125 
Equity income 18  18 
Earnings (loss) before interest and income taxes (216)
Net financing charges 48  47 
Other pension expense
Loss before income taxes (265) (41)
Income tax provision 48 
Net loss (313) (49)
Income attributable to noncontrolling interests 22  21 
Net loss attributable to Adient $ (335) $ (70)
Diluted loss per share $ (3.99) $ (0.77)
Shares outstanding at period end 84.0  89.8 
Diluted weighted average shares 84.0  90.5 



Appendix
Page 2

Adient plc
Condensed Consolidated Statements of Financial Position
(Unaudited)

March 31, September 30,
(in millions) 2025 2024
Assets
Cash and cash equivalents $ 754  $ 945 
Accounts receivable - net
1,887  1,896 
Inventories 719  758 
Other current assets 532  487 
Current assets 3,892  4,086 
Property, plant and equipment - net 1,344  1,410 
Goodwill 1,784  2,164 
Other intangible assets - net 336  371 
Investments in partially-owned affiliates 293  338 
Assets held for sale
Other noncurrent assets 933  974 
Total assets $ 8,589  $ 9,351 
Liabilities and Shareholders' Equity
Short-term debt $ 10  $
Accounts payable and accrued expenses 2,799  2,910 
Other current liabilities 700  759 
Current liabilities 3,509  3,678 
Long-term debt 2,386  2,396 
Other noncurrent liabilities 674  743 
Redeemable noncontrolling interests 71  91 
Shareholders' equity attributable to Adient 1,652  2,134 
Noncontrolling interests 297  309 
Total liabilities and shareholders' equity $ 8,589  $ 9,351 




Appendix
Page 3

Adient plc
Condensed Consolidated Statements of Cash Flows
(Unaudited)
Three Months Ended
March 31,
(in millions) 2025 2024
Operating Activities
Net loss attributable to Adient $ (335) $ (70)
Income attributable to noncontrolling interests 22  21 
Net loss (313) (49)
Adjustments to reconcile net income to cash provided (used) by operating activities:
Depreciation 67  70 
Amortization of intangibles 12  12 
Pension and postretirement benefit expense
Pension and postretirement contributions, net (5) (6)
Equity in earnings of partially-owned affiliates, net of dividends received 29  (14)
Deferred income taxes 10  (1)
Non-cash impairment charges 333  — 
Equity-based compensation 10 
Other
Changes in assets and liabilities:
Receivables (439) (267)
Inventories 18  27 
Other assets (5) 22 
Accounts payable and accrued liabilities 223  292 
Accrued income taxes 12  (20)
Cash provided (used) by operating activities (45) 81 
Investing Activities
Capital expenditures (45) (69)
Sale of property, plant and equipment — 
Other (1) — 
Cash used by investing activities (44) (69)
Financing Activities
Increase (decrease) in short-term debt (7)
Increase in long-term debt 795  — 
Repayment of long-term debt (797) (1)
Debt financing costs (12) (5)
Share repurchases —  (50)
Dividends paid to noncontrolling interests (35) (3)
Cash used by financing activities (47) (66)
Effect of exchange rate changes on cash and cash equivalents 30  (31)
Decrease in cash and cash equivalents $ (106) $ (85)


Appendix
Page 4

Footnotes
1. Segment Results

Adient manages its business on a geographic basis and operates in the following three reportable segments for financial reporting purposes: 1) Americas, which is inclusive of North America and South America; 2) Europe, the Middle East and Africa ("EMEA") and 3) Asia Pacific/China ("Asia").

Adient evaluates the performance of its reportable segments using an adjusted EBITDA metric defined as income before income taxes and noncontrolling interests, excluding net financing charges, restructuring and impairment costs, restructuring related-costs, net mark-to-market adjustments on pension and postretirement plans, transaction gains/losses, purchase accounting amortization, depreciation, stock-based compensation and other non-recurring items. Also, certain corporate-related costs are not allocated to the segments. The reportable segments are consistent with how management views the markets served by Adient and reflect the financial information that is reviewed by its chief operating decision maker.

Financial information relating to Adient's reportable segments is as follows:

(in millions) Three months ended March 31, 2025
Americas EMEA Asia Corporate/Eliminations Consolidated
Net sales $ 1,699  $ 1,231  $ 707  $ (26) $ 3,611 
Adjusted EBITDA $ 94  $ 50  $ 110  $ (21) $ 233 
Adjusted EBITDA margin 5.5  % 4.1  % 15.6  % N/A 6.5  %
Three months ended March 31, 2024
Americas EMEA Asia Corporate/Eliminations Consolidated
Net sales $ 1,660  $ 1,370  $ 742  $ (22) $ 3,750 
Adjusted EBITDA $ 80  $ 57  $ 112  $ (22) $ 227 
Adjusted EBITDA margin 4.8  % 4.2  % 15.1  % N/A 6.1  %



Appendix
Page 5

The following is a reconciliation of Adient's reportable segments' adjusted EBITDA to loss before income taxes:

Three Months Ended
March 31,
(in millions) 2025 2024
Adjusted EBITDA
Americas $ 94  $ 80 
EMEA 50  57 
Asia 110  112 
Subtotal 254  249 
Corporate-related costs (1)
(21) (22)
Restructuring and impairment costs (2)
(351) (125)
Purchase accounting amortization (3)
(12) (13)
Restructuring related activities (4)
(5) (2)
Equity based compensation (5) (10)
Depreciation (67) (70)
Other items (5)
(9)
Earnings (loss) before interest and income taxes $ (216) $
Net financing charges (48) (47)
Other pension expense (1) (2)
Loss before income taxes $ (265) $ (41)

Refer to the Footnote Addendum for footnote explanations.


2. Earnings Per Share

The following table reconciles the numerators and denominators used to calculate basic and diluted loss per share:

Three Months Ended
March 31,
(in millions, except per share data) 2025 2024
Income available to shareholders
Net loss attributable to Adient $ (335) $ (70)
Weighted average shares outstanding
Basic weighted average shares outstanding 84.0  90.5 
Effect of dilutive securities:
Unvested restricted stock and unvested performance share awards —  — 
Diluted weighted average shares outstanding 84.0  90.5 
Loss per share:
Basic $ (3.99) $ (0.77)
Diluted $ (3.99) $ (0.77)

Potentially dilutive securities whose effect would have been antidilutive are excluded from the computation of diluted loss per share, which for the three months ended March 31, 2025 and March 31, 2024 is a result of being in a loss position.


Appendix
Page 6

3. Non-GAAP Measures

Adjusted EBIT, adjusted EBIT margin, adjusted EBITDA, adjusted EBITDA margin, adjusted net income attributable to Adient, adjusted effective tax rate, adjusted earnings per share, adjusted equity income, adjusted interest expense, free cash flow, net debt, and net leverage ratio as well as other measures presented on an adjusted basis are not recognized terms under U.S. GAAP and do not purport to be alternatives to the most comparable U.S. GAAP amounts. Since all companies do not use identical calculations, our definition and presentation of these measures may not be comparable to similarly titled measures reported by other companies. Management uses the identified non-GAAP measures to evaluate the operating performance of Adient and its business segments and to forecast future periods. Management believes these non-GAAP measures assist investors and other interested parties in evaluating Adient's on-going operations and provide important supplemental information to management and investors regarding financial and business trends relating to Adient's financial condition and results of operations. Investors should not consider these non-GAAP measures as alternatives to the related GAAP measures. Reconciliations of non-GAAP measures to their closest U.S. GAAP equivalent are presented in the corresponding tables that follow the definitions below. Reconciliations of non-GAAP measures related to guidance for any future period have not been provided due to the unreasonable efforts it would take to provide such reconciliations.

Table
(a) Adjusted EBIT is defined as loss before income taxes and noncontrolling interests excluding net financing charges, restructuring, impairment and related costs, purchase accounting amortization, transaction gains/losses, other significant non-recurring items, and net mark-to-market adjustments on pension and postretirement plans. Adjusted EBIT margin is adjusted EBIT as a percentage of net sales.
(b) Adjusted EBITDA is defined as adjusted EBIT excluding depreciation and equity based compensation. Certain corporate-related costs are not allocated to the business segments in determining Adjusted EBITDA. Adjusted EBITDA margin is adjusted EBITDA as a percentage of net sales.
(c) Adjusted net income attributable to Adient is defined as net loss attributable to Adient excluding restructuring, impairment and related costs, purchase accounting amortization, transaction gains/losses, other significant non-recurring items, net mark-to-market adjustments on pension and postretirement plans, the tax impact of these items and other discrete tax charges/benefits.
(d) Adjusted income tax expense is defined as income tax expense adjusted for the tax effect of the adjustments to income before income taxes and other discrete tax changes/benefits. Adjusted effective tax rate is defined as adjusted income tax provision as a percentage of adjusted income before income taxes.
(e) Adjusted diluted earnings per share is defined as adjusted net income attributable to Adient divided by diluted weighted average shares.
(f) Adjusted equity income is defined as equity income excluding amortization of Adient's intangible assets related to its non-consolidated joint ventures and other unusual or non-recurring items impacting equity income.
(g) Adjusted interest expense is defined as net financing charges excluding unusual or one-time items impacting interest expense.
(h) Free cash flow is defined as cash provided by operating activities less capital expenditures.
(i) Net debt is calculated as total debt (short-term and long-term) less cash and cash equivalents.
(j) Net leverage ratio is calculated as net debt divided by adjusted EBITDA for the last four quarters.







Appendix
Page 7

Reconciliations of non-GAAP measures to their closest US GAAP equivalent:


(a) & (b) Adjusted EBIT and Adjusted EBITDA

The following table reconciles net loss to EBIT, adjusted EBIT and adjusted EBITDA:

Three Months Ended
March 31,
(in millions) 2025 2024
Net loss $ (313) $ (49)
Net financing charges 48  47 
Other pension expense
Income tax expense 48 
Earnings (loss) before interest and income taxes (EBIT) $ (216) $
EBIT adjustments:
Restructuring and impairment costs (2)
351  125 
Purchase accounting amortization (3)
12  13 
Restructuring related activities (4)
Other items (5)
(1)
EBIT adjustments total 377  139 
Adjusted EBIT $ 161  $ 147 
EBITDA adjustments:
Depreciation 67  70 
Equity based compensation 10 
Adjusted EBITDA $ 233  $ 227 
Net sales $ 3,611  $ 3,750 
Net loss as % of net sales (8.7) % (1.3) %
EBIT as % of net sales (6.0) % 0.2  %
Adjusted EBIT as % of net sales 4.5  % 3.9  %
Adjusted EBITDA as % of net sales 6.5  % 6.1  %

Refer to the Footnote Addendum for footnote explanations.



Appendix
Page 8


(c) Adjusted net income attributable to Adient

The following table reconciles net loss attributable to Adient to adjusted net income attributable to Adient:

Three Months Ended
March 31,
(in millions) 2025 2024
Net loss attributable to Adient $ (335) $ (70)
Net income adjustments:
EBIT adjustments total - see table (a) & (b) 377  139 
Tax impact of EBIT adjustments and other tax items - see table (d) 15  (20)
Fees paid on Term Loan B modifications — 
Write off of deferred financing costs upon repurchase of debt — 
Impact of adjustments on noncontrolling interests (6)
(1) (1)
Net income adjustments total 393  119 
Adjusted net income attributable to Adient $ 58  $ 49 

Refer to the Footnote Addendum for footnote explanations.


(d) Adjusted income tax expense and effective tax rate

The following table reconciles income before income taxes to adjusted income before income taxes, reconciles income tax expense (benefit) to adjusted income tax expense (benefit) and presents the related effective tax rate and adjusted effective tax rate:

Three months ended March 31,
2025 2024
(in millions, except effective tax rate) Income before income taxes Income tax expense (benefit) Effective tax rate Income before income taxes Income tax expense (benefit) Effective tax rate
As reported $ (265) $ 48  (18.1) % $ (41) $ (19.5) %
Adjustments
EBIT adjustments - see table (a) & (b) 377  16  4.2  % 139  2.2  %
NOL DTA adjustments —  (19) nm —  —  nm
UTP establishments —  (9) nm —  —  nm
Tax audit closures and statute expirations —  —  nm —  14  nm
Net financing charges —  nm —  nm
Other —  (3) nm —  nm
Subtotal of adjustments 379  (15) (4.0) % 140  20  14.3  %
As adjusted $ 114  $ 33  28.9  % $ 99  $ 28  28.3  %

nm - not meaningful



Appendix
Page 9

(e) Adjusted diluted earnings per share

The following table shows the calculation of diluted earnings per share on an adjusted basis:

Three Months Ended
March 31,
(in millions, except per share data) 2025 2024
Numerator:
Adjusted net income attributable to Adient - see table (c) $ 58  $ 49 
Denominator:
Basic weighted average shares outstanding 84.0  90.5 
Effect of dilutive securities:
Unvested restricted stock and unvested performance share awards 0.1  0.7 
Diluted weighted average shares outstanding 84.1  91.2 
Adjusted diluted earnings per share $ 0.69  $ 0.54 


The following table reconciles diluted earnings per share as reported to adjusted diluted earnings per share (see table (c) for corresponding dollar amounts):

Three Months Ended
March 31,
2025 2024
Diluted loss per share as reported $ (3.99) $ (0.77)
EBIT adjustments total 4.49  1.54 
Tax impact of EBIT adjustments and other tax items 0.18  (0.23)
Fees paid on Term Loan B modifications —  0.01 
Write off of deferred financing costs upon repurchase of debt 0.02  — 
Impact of adjustments on noncontrolling interests (0.01) (0.01)
Adjusted diluted earnings per share $ 0.69  $ 0.54 


(f) Adjusted equity income

The following table reconciles equity income to adjusted equity income:
Three Months Ended
March 31,
(in millions) 2025 2024
Equity income $ 18  $ 18 
Equity income adjustments:
Non-recurring loss at affiliates — 
Purchase accounting amortization — 
Equity income adjustments total
Adjusted equity income $ 19  $ 19 




Appendix
Page 10

(g) Adjusted interest expense

The following table reconciles net financing charges to adjusted net financing charges:

Three Months Ended
March 31,
(in millions) 2025 2024
Net financing charges $ 48  $ 47 
Interest expense adjustments:
Write off of deferred financing costs upon repurchase of debt (2) — 
Fees paid on Term Loan B modifications —  (1)
Interest expense adjustments total (2) (1)
Adjusted net financing charges $ 46  $ 46 

(h) Free cash flow

The following table reconciles cash from operating activities to free cash flow:

Three Months Ended
March 31,
Six Months Ended
March 31,
(in millions) 2025 2024 2025 2024
Operating cash flow $ (45) $ 81  $ 64  $ 122 
Capital expenditures (45) (69) (109) (124)
Free cash flow $ (90) $ 12  $ (45) $ (2)


The following table reconciles adjusted EBITDA to free cash flow:

Three Months Ended
March 31,
Six Months Ended
March 31,
(in millions) 2025 2024 2025 2024
Adjusted EBITDA $ 233  $ 227  $ 429  $ 443 
Adjusted equity income (18) (19) (39) (44)
Dividends from partially owned affiliates 46  52  21 
Restructuring (cash) (33) (11) (67) (21)
Net customer tooling (2) 19  (18)
Trade working capital (Net AR/AP + Inventory) (226) (76) 35 
Accrued compensation 47  14  (31) (50)
Interest paid (33) (37) (87) (97)
Tax refund/taxes paid (24) (28) (39) (52)
Non-income related taxes (VAT) (18) (21)
Commercial settlements (19) (24) (28) (8)
Net capitalized engineering (17) (12) (11)
Other (3) (2) (86) (75)
Operating cash flow (45) 81  64  122 
Capital expenditures (45) (69) (109) (124)
Free cash flow $ (90) $ 12  $ (45) $ (2)




Appendix
Page 11

(i) & (j) Net debt and net leverage ratio

The following table presents calculations of net debt and net leverage ratio:

March 31, September 30,
(in millions) 2025 2024
Numerator:
Short-term debt $ $
Current portion of long-term debt
Long-term debt 2,386  2,396 
Total debt 2,396  2,405 
Less: cash and cash equivalents 754  945 
Net debt $ 1,642  $ 1,460 
Denominator:
Adjusted EBITDA - last four quarters
Q1 2024 na $ 216 
Q2 2024 na 227 
Q3 2024 202  202 
Q4 2024 235  235 
Q1 2025 196  na
Q2 2025 - see table (a) & (b) 233  na
Last four quarters $ 866  $ 880 
Net leverage ratio 1.90 1.66


Appendix
Page 12

Footnote Addendum

(1) Corporate-related costs not allocated to the segments include executive office, communications, corporate development, legal and corporate finance.

(2) Reflects restructuring charges for costs that are probable and reasonably estimable and one-time asset impairments related
to restructuring activities. During the three months ended March 31, 2025 a goodwill impairment charge of $333 million was recorded.

(3) Reflects amortization of intangible assets including those related to partially owned affiliates recorded within equity income.

(4) Reflects restructuring-related charges for costs that are recorded as incurred or as earned and other non-recurring impacts that are directly attributable to restructuring activities.

(5) Other items include:

Three Months Ended
March 31,
(in millions) 2025 2024
Non-recurring loss at affiliates $ (1) $ — 
Consulting costs associated with strategic planning (8) — 
Brazil indirect tax recoveries — 
$ (9) $

(6) Reflects the impact of adjustments, primarily purchase accounting amortization on noncontrolling interests.